

Ozempic, AI Wearables, Tesla Price Cuts | The Brainstorm EP 18
9 snips Oct 13, 2023
This podcast discusses the weight loss properties of GLP1s and their impact on healthcare spending. It explores the potential risks and drawbacks of the weight loss drug Ozempic. The hosts also talk about AI companions, AI hardware, and challenges of monetization. They highlight the importance of brand trust and storytelling in wearables adoption. Finally, they analyze Tesla's recent price cuts and their implications.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 2min
GLP1s and Rising Healthcare Spending
01:50 • 4min
Downsides and Potential Side Effects of Ozempic Weight Loss Drug
06:00 • 3min
AI Companions, AI Hardware, and Challenges of Monetization
09:28 • 17min
The Importance of Brand Trust and Storytelling in Wearables Adoption
26:35 • 9min
Tesla's Price Cuts and Implications
35:12 • 5min